UA80976C2 - Processes and materials for production of d-lactic acid in yeast - Google Patents
Processes and materials for production of d-lactic acid in yeast Download PDFInfo
- Publication number
- UA80976C2 UA80976C2 UA20041210933A UA20041210933A UA80976C2 UA 80976 C2 UA80976 C2 UA 80976C2 UA 20041210933 A UA20041210933 A UA 20041210933A UA 20041210933 A UA20041210933 A UA 20041210933A UA 80976 C2 UA80976 C2 UA 80976C2
- Authority
- UA
- Ukraine
- Prior art keywords
- gene
- lactic acid
- promoter
- cell according
- terminator
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 68
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 39
- 230000008569 process Effects 0.000 title claims description 41
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims description 25
- 229930182843 D-Lactic acid Natural products 0.000 title abstract 2
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 title abstract 2
- 229940022769 d- lactic acid Drugs 0.000 title abstract 2
- 239000000463 material Substances 0.000 title description 6
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 187
- 210000004027 cell Anatomy 0.000 claims description 148
- 239000004310 lactic acid Substances 0.000 claims description 106
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 100
- 238000000855 fermentation Methods 0.000 claims description 76
- 230000004151 fermentation Effects 0.000 claims description 76
- 101000686031 Homo sapiens Proto-oncogene tyrosine-protein kinase ROS Proteins 0.000 claims description 57
- 102100023347 Proto-oncogene tyrosine-protein kinase ROS Human genes 0.000 claims description 57
- 241000894007 species Species 0.000 claims description 51
- 235000014655 lactic acid Nutrition 0.000 claims description 50
- 210000005253 yeast cell Anatomy 0.000 claims description 45
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 claims description 32
- 108700007698 Genetic Terminator Regions Proteins 0.000 claims description 24
- 150000001720 carbohydrates Chemical class 0.000 claims description 15
- 235000014633 carbohydrates Nutrition 0.000 claims description 15
- 230000015572 biosynthetic process Effects 0.000 claims description 14
- 101710088194 Dehydrogenase Proteins 0.000 claims description 10
- 101150042287 ros gene Proteins 0.000 claims description 10
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims description 8
- 239000002773 nucleotide Substances 0.000 claims description 8
- 125000003729 nucleotide group Chemical group 0.000 claims description 8
- 235000000346 sugar Nutrition 0.000 claims description 8
- 229920001577 copolymer Polymers 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 3
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims 6
- 238000004113 cell culture Methods 0.000 claims 2
- 238000006116 polymerization reaction Methods 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 abstract description 23
- 108090000790 Enzymes Proteins 0.000 abstract description 23
- 239000013604 expression vector Substances 0.000 abstract description 2
- 241000235649 Kluyveromyces Species 0.000 abstract 2
- 239000011942 biocatalyst Substances 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 description 128
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 78
- 239000012634 fragment Substances 0.000 description 65
- 239000000047 product Substances 0.000 description 52
- 239000008103 glucose Substances 0.000 description 51
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 49
- 239000002609 medium Substances 0.000 description 45
- 108020004414 DNA Proteins 0.000 description 38
- 239000013615 primer Substances 0.000 description 38
- 229940076788 pyruvate Drugs 0.000 description 31
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 30
- 238000004458 analytical method Methods 0.000 description 29
- 230000010354 integration Effects 0.000 description 29
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 28
- 238000011534 incubation Methods 0.000 description 28
- 150000007523 nucleic acids Chemical class 0.000 description 27
- 108020004707 nucleic acids Proteins 0.000 description 26
- 102000039446 nucleic acids Human genes 0.000 description 26
- 239000003550 marker Substances 0.000 description 25
- 229940088598 enzyme Drugs 0.000 description 22
- 230000012010 growth Effects 0.000 description 19
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 18
- 238000005119 centrifugation Methods 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- 238000003199 nucleic acid amplification method Methods 0.000 description 17
- 230000037430 deletion Effects 0.000 description 16
- 238000012217 deletion Methods 0.000 description 16
- 230000003321 amplification Effects 0.000 description 15
- 238000010276 construction Methods 0.000 description 15
- 239000011159 matrix material Substances 0.000 description 15
- 229920001817 Agar Polymers 0.000 description 14
- YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 description 14
- 239000008272 agar Substances 0.000 description 14
- 229920001184 polypeptide Polymers 0.000 description 14
- 102000004196 processed proteins & peptides Human genes 0.000 description 14
- 108090000765 processed proteins & peptides Proteins 0.000 description 14
- 238000006467 substitution reaction Methods 0.000 description 14
- 238000004520 electroporation Methods 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- 230000009466 transformation Effects 0.000 description 12
- 230000014509 gene expression Effects 0.000 description 11
- 230000007062 hydrolysis Effects 0.000 description 11
- 238000006460 hydrolysis reaction Methods 0.000 description 11
- 238000003780 insertion Methods 0.000 description 11
- 230000037431 insertion Effects 0.000 description 11
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 10
- 108010084455 Zeocin Proteins 0.000 description 10
- 239000011543 agarose gel Substances 0.000 description 10
- 239000000872 buffer Substances 0.000 description 10
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 10
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 9
- 229910052760 oxygen Inorganic materials 0.000 description 9
- 239000001301 oxygen Substances 0.000 description 9
- 150000001413 amino acids Chemical group 0.000 description 8
- 238000001962 electrophoresis Methods 0.000 description 8
- 244000005700 microbiome Species 0.000 description 8
- 230000003287 optical effect Effects 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 239000013598 vector Substances 0.000 description 8
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 7
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 7
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 7
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 7
- 101150035397 Ros1 gene Proteins 0.000 description 7
- 239000013611 chromosomal DNA Substances 0.000 description 7
- 210000000349 chromosome Anatomy 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 108010011939 Pyruvate Decarboxylase Proteins 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 6
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 6
- 230000002255 enzymatic effect Effects 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 238000002744 homologous recombination Methods 0.000 description 6
- 230000006801 homologous recombination Effects 0.000 description 6
- 238000011081 inoculation Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000005720 sucrose Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 108091026890 Coding region Proteins 0.000 description 5
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 5
- 229910000019 calcium carbonate Inorganic materials 0.000 description 5
- 235000010216 calcium carbonate Nutrition 0.000 description 5
- 238000010367 cloning Methods 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 5
- 230000006798 recombination Effects 0.000 description 5
- 238000005215 recombination Methods 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 238000013518 transcription Methods 0.000 description 5
- 230000035897 transcription Effects 0.000 description 5
- 239000000811 xylitol Substances 0.000 description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 5
- 229960002675 xylitol Drugs 0.000 description 5
- 235000010447 xylitol Nutrition 0.000 description 5
- 239000002028 Biomass Substances 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 244000068988 Glycine max Species 0.000 description 4
- 238000002105 Southern blotting Methods 0.000 description 4
- 101001099217 Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) Triosephosphate isomerase Proteins 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 239000012228 culture supernatant Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 239000012429 reaction media Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 108091029865 Exogenous DNA Proteins 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 101000883801 Homo sapiens Probable ATP-dependent RNA helicase DDX52 Proteins 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 102000011755 Phosphoglycerate Kinase Human genes 0.000 description 3
- 102100038267 Probable ATP-dependent RNA helicase DDX52 Human genes 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000005273 aeration Methods 0.000 description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 3
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 3
- 239000001527 calcium lactate Substances 0.000 description 3
- 229960002401 calcium lactate Drugs 0.000 description 3
- 235000011086 calcium lactate Nutrition 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000004009 herbicide Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 3
- 229940071257 lithium acetate Drugs 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 230000020477 pH reduction Effects 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 230000003234 polygenic effect Effects 0.000 description 3
- 238000004445 quantitative analysis Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000013049 sediment Substances 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000001890 transfection Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- OCKGFTQIICXDQW-ZEQRLZLVSA-N 5-[(1r)-1-hydroxy-2-[4-[(2r)-2-hydroxy-2-(4-methyl-1-oxo-3h-2-benzofuran-5-yl)ethyl]piperazin-1-yl]ethyl]-4-methyl-3h-2-benzofuran-1-one Chemical compound C1=C2C(=O)OCC2=C(C)C([C@@H](O)CN2CCN(CC2)C[C@H](O)C2=CC=C3C(=O)OCC3=C2C)=C1 OCKGFTQIICXDQW-ZEQRLZLVSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000238424 Crustacea Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 241000831652 Salinivibrio sharmensis Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 2
- 108700015934 Triose-phosphate isomerases Proteins 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000010307 cell transformation Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical class C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- -1 hexose sugars Chemical class 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229940127557 pharmaceutical product Drugs 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 108091033319 polynucleotide Chemical group 0.000 description 2
- 239000002157 polynucleotide Chemical group 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000003362 replicative effect Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000006152 selective media Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 description 1
- 101150072531 10 gene Proteins 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- OZZQHCBFUVFZGT-UHFFFAOYSA-N 2-(2-hydroxypropanoyloxy)propanoic acid Chemical compound CC(O)C(=O)OC(C)C(O)=O OZZQHCBFUVFZGT-UHFFFAOYSA-N 0.000 description 1
- 108010039636 3-isopropylmalate dehydrogenase Proteins 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- 101150096316 5 gene Proteins 0.000 description 1
- LPEKGGXMPWTOCB-UHFFFAOYSA-N 8beta-(2,3-epoxy-2-methylbutyryloxy)-14-acetoxytithifolin Natural products COC(=O)C(C)O LPEKGGXMPWTOCB-UHFFFAOYSA-N 0.000 description 1
- 101150011812 AADAC gene Proteins 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 101100412417 Arabidopsis thaliana REM5 gene Proteins 0.000 description 1
- 241000710149 Beet yellows virus Species 0.000 description 1
- 102100036305 C-C chemokine receptor type 8 Human genes 0.000 description 1
- 101100366936 Caenorhabditis elegans sto-3 gene Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102100032566 Carbonic anhydrase-related protein 10 Human genes 0.000 description 1
- 108090000489 Carboxy-Lyases Proteins 0.000 description 1
- 102000004031 Carboxy-Lyases Human genes 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241001274613 Corvus frugilegus Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 240000008005 Crotalaria incana Species 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 108020005199 Dehydrogenases Proteins 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 101000837299 Euglena gracilis Trans-2-enoyl-CoA reductase Proteins 0.000 description 1
- 102000020897 Formins Human genes 0.000 description 1
- 108091022623 Formins Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 244000287680 Garcinia dulcis Species 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 101000716063 Homo sapiens C-C chemokine receptor type 8 Proteins 0.000 description 1
- 101000867836 Homo sapiens Carbonic anhydrase-related protein 10 Proteins 0.000 description 1
- 101000651041 Homo sapiens Swi5-dependent recombination DNA repair protein 1 homolog Proteins 0.000 description 1
- 208000035888 Immune-mediated thrombotic thrombocytopenic purpura Diseases 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 241000018242 Obba <basidiomycete fungus> Species 0.000 description 1
- 102100037214 Orotidine 5'-phosphate decarboxylase Human genes 0.000 description 1
- 108010055012 Orotidine-5'-phosphate decarboxylase Proteins 0.000 description 1
- 102100036201 Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial Human genes 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241001014642 Rasta Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 102100027777 Swi5-dependent recombination DNA repair protein 1 homolog Human genes 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 241000473945 Theria <moth genus> Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 239000002647 aminoglycoside antibiotic agent Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 230000009604 anaerobic growth Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000010945 base-catalyzed hydrolysis reactiony Methods 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229960002713 calcium chloride Drugs 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000002635 electroconvulsive therapy Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 230000002414 glycolytic effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000002743 insertional mutagenesis Methods 0.000 description 1
- 238000010409 ironing Methods 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 238000013178 mathematical model Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 229940057867 methyl lactate Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000010413 mother solution Substances 0.000 description 1
- 108010009719 mutanolysin Proteins 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- KYOBSHFOBAOFBF-XVFCMESISA-N orotidine 5'-phosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1C(O)=O KYOBSHFOBAOFBF-XVFCMESISA-N 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 238000000059 patterning Methods 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000006861 primary carbon metabolism Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 150000003628 tricarboxylic acids Chemical class 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/56—Lactic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
- C12P7/625—Polyesters of hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
- G01N2333/39—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38433302P | 2002-05-30 | 2002-05-30 | |
PCT/US2003/017310 WO2003102201A2 (en) | 2002-05-30 | 2003-05-30 | Methods and materials for the production of d-lactic acid in yeast |
Publications (1)
Publication Number | Publication Date |
---|---|
UA80976C2 true UA80976C2 (en) | 2007-11-26 |
Family
ID=29712012
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UA20041210933A UA80976C2 (en) | 2002-05-30 | 2003-05-30 | Processes and materials for production of d-lactic acid in yeast |
UA20041210932A UA88437C2 (ru) | 2002-05-30 | 2003-05-30 | Процесс ферментации при участии генетически модифицированых дрожжей и способ осуществления ферментации |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UA20041210932A UA88437C2 (ru) | 2002-05-30 | 2003-05-30 | Процесс ферментации при участии генетически модифицированых дрожжей и способ осуществления ферментации |
Country Status (15)
Country | Link |
---|---|
US (7) | US7534597B2 (zh) |
EP (4) | EP2878675B1 (zh) |
JP (4) | JP2005528112A (zh) |
CN (4) | CN101157930A (zh) |
AT (1) | ATE367436T1 (zh) |
AU (4) | AU2003243366B2 (zh) |
BR (4) | BR0311452A (zh) |
CA (3) | CA2487116C (zh) |
DE (1) | DE60315028T2 (zh) |
DK (1) | DK2878675T3 (zh) |
ES (3) | ES2529254T3 (zh) |
PT (1) | PT1513923E (zh) |
UA (2) | UA80976C2 (zh) |
WO (3) | WO2003102200A2 (zh) |
ZA (3) | ZA200409530B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2553563C2 (ru) * | 2009-06-03 | 2015-06-20 | Торэй Индастриз, Инк. | Полипептид, обладающий активностью d-лактатдегидрогеназы, полинуклеотид, кодирующий этот полипептид, и способ получения d-молочной кислоты |
Families Citing this family (117)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1294728B1 (it) * | 1997-09-12 | 1999-04-12 | Biopolo S C A R L | Ceppi di lievito per la riproduzione di acido lattico |
US20070031950A1 (en) * | 1998-09-11 | 2007-02-08 | Winkler Aaron A | Production of D-lactic acid with yeast |
US7141410B2 (en) * | 2000-11-22 | 2006-11-28 | Natureworks Llc | Methods and materials for the production of organic products in cells of Candida species |
BR0311452A (pt) | 2002-05-30 | 2005-03-29 | Cargill Dow Llc | Processos e materiais para a produção de ácido lático em levedura |
EP1626979B1 (en) | 2003-05-02 | 2012-06-06 | Cargill, Incorporated | Genetically modified yeast species and fermentation processes using genetically modified yeast |
JP4460876B2 (ja) * | 2003-11-07 | 2010-05-12 | 株式会社豊田中央研究所 | 有機酸存在下におけるプロモーター及びその利用 |
US20050112737A1 (en) * | 2003-11-20 | 2005-05-26 | A. E. Staley Manufacturing Co. | Lactic acid producing yeast |
JP4806904B2 (ja) * | 2004-07-09 | 2011-11-02 | トヨタ自動車株式会社 | 乳酸生産方法 |
JP2006296377A (ja) * | 2005-04-25 | 2006-11-02 | Toyota Central Res & Dev Lab Inc | 有機酸生産用形質転換体 |
AU2006291566A1 (en) | 2005-06-02 | 2007-03-22 | Cargill, Inc. | Genetically modified yeast of the species issatchenkia orientalis and closely related species and fermentation processes using same |
PL2305826T3 (pl) | 2005-08-10 | 2016-10-31 | Materiały i sposoby do wydajnej produkcji kwasu mlekowego | |
JP4692173B2 (ja) * | 2005-09-13 | 2011-06-01 | 東レ株式会社 | D−乳酸デヒドロゲナーゼ活性を有するポリペプチド、これをコードする遺伝子およびd−乳酸の製造方法 |
US7718405B2 (en) * | 2005-09-19 | 2010-05-18 | American Air Liquide, Inc. | Use of pure oxygen in viscous fermentation processes |
CA2623751A1 (en) | 2005-09-22 | 2007-04-05 | Tate & Lyle Ingredients Americas, Inc. | Improved strains for the production of organic acids |
EP2147976B1 (en) * | 2005-10-14 | 2014-07-23 | Toray Industries, Inc. | Yeast and method of producing L-lactic acid |
WO2007117282A2 (en) | 2005-11-23 | 2007-10-18 | Natureworks Llc | Lactic acid-producing yeast cells having nonfunctional l-or d-lactate: ferricytochrome c oxidoreductase gene |
WO2007085443A2 (en) | 2006-01-24 | 2007-08-02 | Purac Biochem Bv | Genetic modification of homolactic thermophilic bacilli |
CA2645361A1 (en) | 2006-03-13 | 2007-09-20 | Cargill Inc. | Yeast cells having disrupted pathway from dihydroxyacetone phosphate to glycerol |
JP5320692B2 (ja) * | 2006-06-28 | 2013-10-23 | 東レ株式会社 | 酵母及びl−乳酸の製造方法 |
US20080064076A1 (en) * | 2006-09-11 | 2008-03-13 | Saucedo Victor M | Dissolved Oxygen Profile to Increase Fermentation Productivity and Economics |
JP5141126B2 (ja) * | 2006-09-26 | 2013-02-13 | 東レ株式会社 | 連続発酵によるd−乳酸の製造方法 |
MX2009004659A (es) * | 2006-10-31 | 2009-05-22 | Metabolic Explorer Sa | Procedimiento para la produccion biologica de 1,3-propanodiol a partir de glicerina con un alto rendimiento. |
WO2008052596A1 (en) * | 2006-10-31 | 2008-05-08 | Metabolic Explorer | Process for the biological production of n-butanol with high yield |
CN101743310A (zh) | 2006-12-07 | 2010-06-16 | 麻省理工学院 | 全局转录机器的改造 |
JP5130826B2 (ja) * | 2007-03-28 | 2013-01-30 | 東レ株式会社 | 連続発酵による乳酸の製造方法 |
JP2008283917A (ja) * | 2007-05-18 | 2008-11-27 | Toray Ind Inc | 乳酸の製造方法 |
DK2217711T3 (en) | 2007-09-20 | 2015-09-14 | Amyris Inc | Production of isoprenoids |
JP5532919B2 (ja) * | 2007-12-07 | 2014-06-25 | 東レ株式会社 | 乳酸脱水素酵素発現カセット、形質転換酵母および乳酸の製造方法 |
EP2235193B1 (en) | 2007-12-23 | 2015-11-25 | GEVO, Inc. | Yeast organism producing isobutanol at a high yield |
US8455239B2 (en) | 2007-12-23 | 2013-06-04 | Gevo, Inc. | Yeast organism producing isobutanol at a high yield |
EP2238098A4 (en) | 2007-12-27 | 2016-06-01 | Gevo Inc | RECOVERING HIGHER ALCOHOLS IN DILUTED AQUEOUS SOLUTIONS |
CN101939439B (zh) * | 2008-02-04 | 2014-08-06 | 东丽株式会社 | 通过连续发酵实施的乳酸的制造方法 |
US20090235951A1 (en) * | 2008-03-18 | 2009-09-24 | Legrande W E | Environmentally Responsible Dental Floss and Packaging |
JP4963488B2 (ja) * | 2008-04-23 | 2012-06-27 | トヨタ自動車株式会社 | 変異体酵母及びこれを用いた物質生産方法 |
CA2730595C (en) * | 2008-07-08 | 2014-12-16 | Dsm Ip Assets B.V. | Low ph dicarboxylic acid production |
KR101613754B1 (ko) | 2008-10-03 | 2016-04-19 | 메타볼릭 익스플로러 | 강하 막, 와이프드 막, 박막 또는 단경로 증발기를 사용한 발효 브로쓰로부터의 알콜의 정제 방법 |
JPWO2010084972A1 (ja) * | 2009-01-23 | 2012-07-19 | 株式会社アグリバイオインダストリ | D−乳酸の製造方法および乳酸においてd−乳酸の光学純度または対糖収率を高める方法 |
CN102482689A (zh) * | 2009-06-26 | 2012-05-30 | 格沃股份有限公司 | 从稀水溶液回收高级醇 |
WO2011003034A2 (en) | 2009-07-02 | 2011-01-06 | Verdezyne, Inc. | Biological methods for preparing adipic acid |
CN102471787B (zh) * | 2009-07-28 | 2016-01-20 | 三井化学株式会社 | 乳酸制造方法 |
CN102575235B (zh) | 2009-07-30 | 2015-05-20 | 代谢探索者公司 | 用于通过发酵生产生物化学品的突变甲基乙二醛合酶(mgs) |
US9783834B2 (en) | 2009-08-27 | 2017-10-10 | Dsm Ip Assets B.V. | Dicarboxylic acid fermentation process |
CN102596866A (zh) * | 2009-10-06 | 2012-07-18 | 格沃股份有限公司 | 将可再生异丁醇选择性转化为对二甲苯的整体工艺 |
WO2011131667A1 (en) | 2010-04-21 | 2011-10-27 | Dsm Ip Assets B.V. | Cell suitable for fermentation of a mixed sugar composition |
US9012190B2 (en) | 2011-06-15 | 2015-04-21 | Butamax Advanced Biofuels Llc | Use of thiamine and nicotine adenine dinucleotide for butanol production |
CA2807102C (en) | 2010-07-31 | 2018-08-21 | Myriant Corporation | Improved fermentation process for the production of organic acids |
WO2012049170A2 (en) | 2010-10-13 | 2012-04-19 | Dsm Ip Assets B.V. | Pentose and glucose fermenting yeast cell |
WO2012071470A2 (en) | 2010-11-22 | 2012-05-31 | Cargill, Incorporated | Compositions and methods for increased ethanol titer from biomass |
CA2818499A1 (en) | 2010-11-22 | 2012-06-07 | Novozymes, Inc. | Compositions and methods for 3-hydroxypropionic acid production |
WO2012103261A2 (en) | 2011-01-25 | 2012-08-02 | Finley Kenneth R | Compositions and methods for succinate production |
CN103649306B (zh) * | 2011-03-29 | 2015-07-01 | 雀巢产品技术援助有限公司 | 在d乳酸生产中有缺陷以及具有改善的免疫特征的约氏乳杆菌菌株cncm i-1225的天然衍生物 |
GB2505148B8 (en) | 2011-04-07 | 2016-12-07 | Virdia Ltd | Lignocellulose conversion processes and products |
EP2697252B1 (en) | 2011-04-11 | 2016-08-10 | Cargill, Incorporated | Compositions and methods for increased ethanol production from biomass |
AR086471A1 (es) | 2011-04-22 | 2013-12-18 | Dsm Ip Assets Bv | Celula de levadura capaz de convertir azucares que incluyen arabinosa y xilosa |
US8728798B2 (en) | 2011-05-03 | 2014-05-20 | Verdezyne, Inc. | Biological methods for preparing adipic acid |
US8343752B2 (en) | 2011-05-03 | 2013-01-01 | Verdezyne, Inc. | Biological methods for preparing adipic acid |
CN102285664B (zh) * | 2011-05-27 | 2013-06-19 | 广西崇左市湘桂糖业有限公司 | 模拟移动床分离l-乳酸和d-乳酸专用分子筛及其制备方法 |
WO2013022070A1 (ja) * | 2011-08-11 | 2013-02-14 | 三井化学株式会社 | 連続培養によるイソプロピルアルコール製造方法 |
WO2013112939A2 (en) * | 2012-01-25 | 2013-08-01 | Cargill, Incorporated | Methods for succinate production |
US20150010899A1 (en) * | 2012-02-22 | 2015-01-08 | Novozymes A/S | Advanced fermentation control |
FR2988733B1 (fr) * | 2012-03-27 | 2016-02-05 | Carbios | Microorganisme recombinant |
KR101438882B1 (ko) * | 2012-04-24 | 2014-09-05 | 씨제이제일제당 (주) | 신규한 d형 젖산 생산균주 |
US9493851B2 (en) | 2012-05-03 | 2016-11-15 | Virdia, Inc. | Methods for treating lignocellulosic materials |
SG11201407183SA (en) | 2012-05-03 | 2014-12-30 | Virdia Ltd | Methods for treating lignocellulosic materials |
KR101576186B1 (ko) * | 2012-06-26 | 2015-12-10 | 한국생명공학연구원 | 에탄올 생산 경로가 봉쇄된 클루이베로마이세스 막시아누스 균주 및 이의 용도 |
EP2877568B1 (en) | 2012-07-25 | 2021-04-28 | Cargill, Incorporated | Yeast cells having reductive tca pathway from pyruvate to succinate and overexpressing an exogenous nad(p)+ transhydrogenase enzyme |
WO2014043591A1 (en) * | 2012-09-14 | 2014-03-20 | Myriant Corporation | Production of organic acids by fermentation at low ph |
PL2909305T3 (pl) | 2012-10-16 | 2019-06-28 | Dsm Ip Assets B.V. | Komórki o ulepszonej konwersji pentozy |
BR112015010139A2 (pt) | 2012-11-07 | 2017-07-11 | Dsm Ip Assets Bv | propagação de levedura com ph controlado |
WO2014076232A2 (en) | 2012-11-19 | 2014-05-22 | Novozymes A/S | Isopropanol production by recombinant hosts using an hmg-coa intermediate |
BR112015012409A2 (pt) | 2012-11-30 | 2017-09-12 | Novozymes Inc | célula recombinante de levedura, e, método de produção de 3-hp |
CA2914641A1 (en) | 2013-06-18 | 2014-12-24 | Calysta, Inc. | Compositions and methods for biological production of lactate from c1 compounds using lactate dehydrogenase transformants |
WO2015017721A1 (en) | 2013-07-31 | 2015-02-05 | Novozymes A/S | 3-hydroxypropionic acid production by recombinant yeasts expressing an insect aspartate 1-decarboxylase |
CA2936850A1 (en) | 2014-01-16 | 2015-07-23 | Calysta, Inc. | Carbohydrate-enriched recombinant microorganisms |
KR20150096019A (ko) * | 2014-02-13 | 2015-08-24 | 삼성전자주식회사 | 유전자 조작 효율이 향상된 효모 세포 및 그의 용도 |
US9593350B2 (en) | 2014-02-14 | 2017-03-14 | Samsung Electronics Co., Ltd. | Lactate dehydrogenase mutant, polynucleotide coding for the mutant, yeast cell including the polynucleotide, method of preparing the mutant, and method of producing the lactate using the same |
JP6183263B2 (ja) * | 2014-03-28 | 2017-08-23 | 王子ホールディングス株式会社 | D−乳酸の精製のための工程が改良されたd−乳酸の製造方法 |
PT3143075T (pt) | 2014-05-16 | 2022-08-12 | Carbios | Processo de reciclagem de artigos de plástico pet mistos |
WO2016012429A1 (en) | 2014-07-24 | 2016-01-28 | Dsm Ip Assets B.V. | Yeast cell with improved pentose transport |
KR102245298B1 (ko) | 2014-09-05 | 2021-04-27 | 삼성전자주식회사 | 증가된 edc 활성을 갖고 락테이트 생산능을 갖는 유전적으로 조작된 효모 세포, 그를 제조하는 방법, 그를 제조하는 방법, 및 그를 사용하여 락테이트를 생산하는 방법 |
US10214754B2 (en) | 2014-10-10 | 2019-02-26 | Jmtc Enzyme Corporation | Transformant and its production process, and method for producing lactic acid |
DK3209771T3 (da) | 2014-10-21 | 2021-01-11 | Carbios | Polypeptid med en polyester-nedbrydende aktivitet og anvendelser deraf |
US10465214B2 (en) | 2014-11-20 | 2019-11-05 | Full Cycle Bioplastics Llc | Producing resins from organic waste products |
JP6711278B2 (ja) * | 2014-11-28 | 2020-06-17 | 味の素株式会社 | イソプレノイド化合物の製造方法 |
EP3233995B1 (en) | 2014-12-19 | 2023-08-09 | Carbios | Plastic compound and preparation process |
WO2016100910A1 (en) | 2014-12-19 | 2016-06-23 | Novozymes A/S | Recombinant host cells for the production of 3-hydroxypropionic acid |
SE538899C2 (en) | 2015-02-03 | 2017-01-31 | Stora Enso Oyj | Method for treating lignocellulosic materials |
WO2016138303A1 (en) | 2015-02-27 | 2016-09-01 | Novozymes A/S | Mutant host cells for the production of 3-hydroxypropionic acid |
US10508269B2 (en) | 2015-03-13 | 2019-12-17 | Carbios | Polypeptide having a polyester degrading activity and uses thereof |
JP2018526969A (ja) | 2015-06-04 | 2018-09-20 | バイオアンバー インコーポレイテッドBioamber Inc. | 官能基化アルファ置換アクリレートおよびc4ジカルボキシレートのバイオベース産生 |
JP6907132B2 (ja) | 2015-06-12 | 2021-07-21 | キャルビオスCarbios | 生分解性ポリエステル組成物及びその使用 |
WO2017035270A1 (en) | 2015-08-24 | 2017-03-02 | Novozymes A/S | Beta-alanine aminotransferases for the production of 3-hydroxypropionic acid |
WO2017108577A1 (en) | 2015-12-21 | 2017-06-29 | Carbios | Recombinant yeast cells producing polylactic acid and uses thereof |
WO2017198786A1 (en) | 2016-05-19 | 2017-11-23 | Carbios | A process for degrading plastic products |
CN109689864B (zh) | 2016-07-13 | 2023-04-04 | 帝斯曼知识产权资产管理有限公司 | 苹果酸脱氢酶 |
JP2020506702A (ja) | 2017-02-02 | 2020-03-05 | カーギル インコーポレイテッド | C6−c10脂肪酸誘導体を生成する遺伝子組み換え細胞 |
US11718820B2 (en) | 2017-08-17 | 2023-08-08 | Cargill, Incorporated | Genetically modified haploid Issatchenkia orientalis |
WO2019159011A2 (en) * | 2018-02-16 | 2019-08-22 | Ptt Global Chemical Public Company Limited | Microorganisms and processes for lactic acid production |
WO2019191761A1 (en) * | 2018-03-30 | 2019-10-03 | Invista North America S.A.R.L. | Method for controlling dissolved oxygen concentration in a continuous aerobic fermentation |
CN111886345B (zh) | 2018-03-30 | 2023-09-15 | 英威达纺织(英国)有限公司 | 高氢气利用率和气体再循环 |
KR102140596B1 (ko) | 2018-04-17 | 2020-08-04 | 에스케이이노베이션 주식회사 | 유기산 내성 효모 유래 신규 프로모터 및 이를 이용한 목적유전자의 발현방법 |
KR102140597B1 (ko) | 2018-04-17 | 2020-08-03 | 에스케이이노베이션 주식회사 | 에탄올 생산 경로가 억제된 내산성 효모 및 이를 이용한 젖산의 제조방법 |
US11702680B2 (en) | 2018-05-02 | 2023-07-18 | Inv Nylon Chemicals Americas, Llc | Materials and methods for controlling PHA biosynthesis in PHA-generating species of the genera Ralstonia or Cupriavidus and organisms related thereto |
EP3788148A1 (en) | 2018-05-02 | 2021-03-10 | INVISTA Textiles (U.K.) Limited | Materials and methods for maximizing biosynthesis through alteration of pyruvate-acetyl-coa-tca balance in species of the genera ralstonia and cupriavidus and organisms related thereto |
TWI719317B (zh) * | 2018-06-13 | 2021-02-21 | 遠東新世紀股份有限公司 | 用於生產乳酸的方法 |
CN109097293B (zh) * | 2018-07-13 | 2021-10-26 | 广东利世康低碳科技有限公司 | 一种能降解利用餐厨废弃物生成乳酸的基因重组毕赤酵母 |
KR20200040017A (ko) | 2018-10-08 | 2020-04-17 | 에스케이이노베이션 주식회사 | 알코올 생성이 억제된 재조합 내산성 효모 및 이를 이용한 젖산의 제조방법 |
WO2020110300A1 (ja) | 2018-11-30 | 2020-06-04 | 株式会社Co2資源化研究所 | 乳酸を生成するヒドロゲノフィラス属細菌形質転換体 |
US20220290109A1 (en) | 2019-08-09 | 2022-09-15 | Utilization Of Carbon Dioxide Institute Co., Ltd. | A Recombinant of Hydrogenophilus Bacterium Producing Lactic Acid |
US12018245B2 (en) * | 2019-08-19 | 2024-06-25 | Ptt Global Chemical Public Company Limited | Yeast having improvement of lactic acid tolerance and use thereof |
TWI730383B (zh) * | 2019-08-21 | 2021-06-11 | 遠東新世紀股份有限公司 | 重組型假絲酵母菌菌株及其製備方法與用途 |
KR20210041903A (ko) | 2019-10-08 | 2021-04-16 | 에스케이이노베이션 주식회사 | 락테이트 대사 및 알코올 생성이 억제된 재조합 내산성 효모 및 이를 이용한 젖산의 제조방법 |
KR20210158676A (ko) | 2020-06-24 | 2021-12-31 | 에스케이이노베이션 주식회사 | 젖산 생산능이 증가된 재조합 내산성 효모 |
RU2752896C1 (ru) * | 2020-12-04 | 2021-08-11 | Федеральное государственное бюджетное учреждение "Государственный научно-исследовательский институт генетики и селекции промышленных микроорганизмов Национального исследовательского центра "Курчатовский институт" - ГосНИИгенетика) | Штамм дрожжей Schizosaccharomyces pombe, продуцирующий L-молочную кислоту, содержащий в составе хромосомы гены трех различных гетерологичных лактатдегидрогеназ |
KR102287114B1 (ko) * | 2021-01-25 | 2021-08-06 | 씨제이제일제당 주식회사 | 신규한 사이토신 퍼미에이즈 변이체 및 이를 이용한 l-트립토판 생산 방법 |
WO2022241027A1 (en) * | 2021-05-13 | 2022-11-17 | Lygos, Inc. | Recombinant host cells and methods for producing l-lactic acid |
CN113430127B (zh) * | 2021-07-07 | 2024-01-12 | 江南大学 | 一种产l-乳酸的重组菌及其应用 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3384553A (en) * | 1965-04-08 | 1968-05-21 | Ceskoslovenska Akademie Ved | Method and equipment for aerobic fermentation on liquid culture mediums |
IL39710A (en) | 1972-06-19 | 1975-04-25 | Imi Inst For Res & Dev | Recovery of acids from aqueous solutions by solvent extraction |
US4064015A (en) * | 1975-05-12 | 1977-12-20 | New Brunswick Scientific Co., Inc. | Control of biosynthesis in submerged culture |
US4771001A (en) | 1986-03-27 | 1988-09-13 | Neurex Corp. | Production of lactic acid by continuous fermentation using an inexpensive raw material and a simplified method of lactic acid purification |
US5210296A (en) | 1990-11-19 | 1993-05-11 | E. I. Du Pont De Nemours And Company | Recovery of lactate esters and lactic acid from fermentation broth |
US5132456A (en) | 1991-05-07 | 1992-07-21 | The Regents Of The University Of California | Sorption of carboxylic acid from carboxylic salt solutions at PHS close to or above the pKa of the acid, with regeneration with an aqueous solution of ammonia or low-molecular-weight alkylamine |
JP3012377B2 (ja) * | 1991-10-11 | 2000-02-21 | 名糖産業株式会社 | 低耐熱性プロテアーゼとその関連物及びその生産法 |
US5247059A (en) * | 1992-01-24 | 1993-09-21 | Cargill, Incorporated | Continuous process for the manufacture of a purified lactide from esters of lactic acid |
US5142023A (en) | 1992-01-24 | 1992-08-25 | Cargill, Incorporated | Continuous process for manufacture of lactide polymers with controlled optical purity |
US5420304A (en) | 1992-03-19 | 1995-05-30 | Biopak Technology, Ltd. | Method to produce cyclic esters |
FR2693463B1 (fr) * | 1992-07-08 | 1994-09-02 | Rhone Poulenc Rorer Sa | Promoteur de levure et son utilisation. |
US5338822A (en) | 1992-10-02 | 1994-08-16 | Cargill, Incorporated | Melt-stable lactide polymer composition and process for manufacture thereof |
AT398982B (de) | 1993-02-18 | 1995-02-27 | Vogelbusch Gmbh | Verfahren zur abtrennung und reinigung von milchsäure |
US5510526A (en) | 1993-06-29 | 1996-04-23 | Cargill, Incorporated | Lactic acid production, separation and/or recovery process |
IL109003A (en) | 1994-03-16 | 1999-09-22 | Yissum Res Dev Co | Process and extractant composition for extracting water-soluble carboxylic and mineral acids |
JPH08173170A (ja) * | 1994-05-25 | 1996-07-09 | Kirin Brewery Co Ltd | キャンディダ・ユティリス酵母の形質転換系、およびそれによる異種遺伝子の発現 |
ATE365805T1 (de) * | 1997-05-03 | 2007-07-15 | Nestle Sa | Herstellung von l(+)-lactat |
IT1294728B1 (it) * | 1997-09-12 | 1999-04-12 | Biopolo S C A R L | Ceppi di lievito per la riproduzione di acido lattico |
US6229046B1 (en) * | 1997-10-14 | 2001-05-08 | Cargill, Incorported | Lactic acid processing methods arrangements and products |
US6046002A (en) * | 1998-01-05 | 2000-04-04 | The Board Of Trustees Of The Leland Stanford Junior University | Highly parallel and sensitive method for identifying drugs and drug targets |
WO2000029604A1 (en) * | 1998-11-18 | 2000-05-25 | The University Of Akron | Production of biological materials by simultaneous aerobic and anaerobic respiration |
CA2374482C (en) * | 1999-05-21 | 2012-09-18 | Cargill Dow Llc | Methods and materials for the synthesis of organic products |
US6268189B1 (en) * | 2000-03-24 | 2001-07-31 | The United States Of America As Represented By The Secretary Of Agriculture | Fungal lactate dehydrogenase gene and constructs for the expression thereof |
JP2002136293A (ja) * | 2000-08-23 | 2002-05-14 | Toray Ind Inc | 微生物およびd−乳酸の製造方法 |
AU3944002A (en) * | 2000-11-03 | 2002-05-27 | Genentech Inc | Metabolic rate shifts in fermentations expressing recombinant proteins |
CN1955299A (zh) * | 2000-11-22 | 2007-05-02 | 内特尔沃克公司 | 合成有机产物的方法和材料 |
US7141410B2 (en) * | 2000-11-22 | 2006-11-28 | Natureworks Llc | Methods and materials for the production of organic products in cells of Candida species |
KR100426990B1 (ko) * | 2001-06-27 | 2004-04-13 | 삼성전자주식회사 | 외부의 코드에 따라 프로그래머블하게 기준 전압을 발생시키는 기준 전압 발생 회로 |
EP1484407B1 (en) * | 2002-03-11 | 2011-10-26 | Toyota Jidosha Kabushiki Kaisha | Method of controlling ethanol production and mass production of lactic acid and transformant therefor |
BR0311452A (pt) | 2002-05-30 | 2005-03-29 | Cargill Dow Llc | Processos e materiais para a produção de ácido lático em levedura |
BRPI0410550A (pt) * | 2003-05-22 | 2006-06-20 | Toyota Motor Co Ltd | dna que codifica uma proteìna que tem atividade de d-lactano desidrogenase e seus usos |
-
2003
- 2003-05-30 BR BR0311452-0A patent/BR0311452A/pt not_active IP Right Cessation
- 2003-05-30 AU AU2003243366A patent/AU2003243366B2/en not_active Ceased
- 2003-05-30 DE DE60315028T patent/DE60315028T2/de not_active Expired - Lifetime
- 2003-05-30 EP EP14198669.5A patent/EP2878675B1/en not_active Expired - Lifetime
- 2003-05-30 UA UA20041210933A patent/UA80976C2/uk unknown
- 2003-05-30 ES ES03756237.8T patent/ES2529254T3/es not_active Expired - Lifetime
- 2003-05-30 CN CNA2007101278989A patent/CN101157930A/zh active Pending
- 2003-05-30 BR BRPI0311517-8A patent/BRPI0311517B1/pt unknown
- 2003-05-30 CN CNB038172917A patent/CN100335626C/zh not_active Expired - Fee Related
- 2003-05-30 JP JP2004510438A patent/JP2005528112A/ja active Pending
- 2003-05-30 JP JP2004510437A patent/JP4318638B2/ja not_active Expired - Fee Related
- 2003-05-30 CN CN038172941A patent/CN1735683B/zh not_active Expired - Fee Related
- 2003-05-30 AU AU2003240481A patent/AU2003240481B8/en not_active Ceased
- 2003-05-30 JP JP2004510394A patent/JP2005528106A/ja active Pending
- 2003-05-30 US US10/452,038 patent/US7534597B2/en not_active Expired - Lifetime
- 2003-05-30 UA UA20041210932A patent/UA88437C2/ru unknown
- 2003-05-30 US US10/449,978 patent/US20040029256A1/en not_active Abandoned
- 2003-05-30 BR BRPI0311517A patent/BRPI0311517A2/pt active IP Right Grant
- 2003-05-30 AU AU2003251381A patent/AU2003251381B2/en not_active Ceased
- 2003-05-30 CA CA2487116A patent/CA2487116C/en not_active Expired - Lifetime
- 2003-05-30 ES ES14198669.5T patent/ES2642928T3/es not_active Expired - Lifetime
- 2003-05-30 US US10/449,911 patent/US7232664B2/en active Active
- 2003-05-30 WO PCT/US2003/016825 patent/WO2003102200A2/en active Application Filing
- 2003-05-30 WO PCT/US2003/017310 patent/WO2003102201A2/en active IP Right Grant
- 2003-05-30 EP EP03756237.8A patent/EP1513939B1/en not_active Expired - Lifetime
- 2003-05-30 CA CA002488196A patent/CA2488196A1/en not_active Abandoned
- 2003-05-30 BR BR0311453-8A patent/BR0311453A/pt not_active Application Discontinuation
- 2003-05-30 AT AT03731489T patent/ATE367436T1/de not_active IP Right Cessation
- 2003-05-30 PT PT03731489T patent/PT1513923E/pt unknown
- 2003-05-30 ES ES03731489T patent/ES2290466T3/es not_active Expired - Lifetime
- 2003-05-30 EP EP03756356A patent/EP1513940A4/en not_active Withdrawn
- 2003-05-30 DK DK14198669.5T patent/DK2878675T3/en active
- 2003-05-30 CN CN03817295XA patent/CN1735691B/zh not_active Expired - Fee Related
- 2003-05-30 WO PCT/US2003/017329 patent/WO2003102152A2/en active Application Filing
- 2003-05-30 EP EP03731489A patent/EP1513923B1/en not_active Expired - Lifetime
- 2003-05-30 CA CA002487296A patent/CA2487296A1/en not_active Abandoned
-
2004
- 2004-11-25 ZA ZA200409530A patent/ZA200409530B/en unknown
- 2004-11-25 ZA ZA200409531A patent/ZA200409531B/en unknown
- 2004-11-25 ZA ZA200409529A patent/ZA200409529B/en unknown
-
2007
- 2007-02-14 US US11/707,188 patent/US7939298B2/en active Active
-
2008
- 2008-07-03 AU AU2008202963A patent/AU2008202963A1/en not_active Abandoned
- 2008-08-13 JP JP2008208544A patent/JP2009000124A/ja active Pending
-
2009
- 2009-01-12 US US12/352,133 patent/US20100137551A1/en not_active Abandoned
-
2011
- 2011-04-01 US US13/078,128 patent/US8828707B2/en not_active Expired - Lifetime
-
2014
- 2014-09-06 US US14/479,309 patent/US9428776B2/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2553563C2 (ru) * | 2009-06-03 | 2015-06-20 | Торэй Индастриз, Инк. | Полипептид, обладающий активностью d-лактатдегидрогеназы, полинуклеотид, кодирующий этот полипептид, и способ получения d-молочной кислоты |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA80976C2 (en) | Processes and materials for production of d-lactic acid in yeast | |
CN109402158B (zh) | 一种产岩藻糖基乳糖的重组表达质粒载体、代谢工程菌及生产方法 | |
US20210254031A1 (en) | Engineered strain for producing allulose and derivatives thereof, method for construction therefor and use thereof | |
Zhang et al. | Enhancing fructooligosaccharides production by genetic improvement of the industrial fungus Aspergillus niger ATCC 20611 | |
KR101511639B1 (ko) | 재조합 미생물 및 이의 사용 방법 | |
CN104508136A (zh) | 重组微生物及其用途 | |
KR20150068925A (ko) | 변형된 미생물 및 이를 사용하여 부타디엔을 만드는 방법 | |
CN108676766B (zh) | 基因修饰的应用及其获得的菌株 | |
EA025990B1 (ru) | Полипептиды с оксидоредуктазной активностью и их применение | |
KR102345898B1 (ko) | 글루코오스 투과 효소 라이브러리를 생성하는 방법 및 이의 용도 | |
JP2020501595A (ja) | キシリトールを生産するメチニコビア種 | |
CN117645967A (zh) | 一种适用于高密度发酵产酶的枯草芽孢杆菌底盘细胞 | |
CN116064345A (zh) | 高效生产岩藻糖基乳糖的无抗基因工程菌及其应用 | |
US10995123B2 (en) | Pyruvate transporter | |
CN112126615B (zh) | 一种产丁酸的枯草芽孢杆菌及其构建方法和应用 | |
CN107223152B (zh) | 具有改变的一氧化碳脱氢酶(codh)活性的遗传工程细菌 | |
KR20220096752A (ko) | 푸코오스 전이효소를 발현하는 재조합 미생물 및 이를 이용한 2’-푸코실락토오스 제조방법 | |
KR102320074B1 (ko) | 재조합 미생물의 생산 방법 | |
CN107299074B (zh) | 甲酸脱氢酶工程菌株的构建方法及应用 | |
KR20180124782A (ko) | 바이오매스에서 유래한 탄소원의 고성능 대사를 위한 신규 미생물 균주 | |
KR102683624B1 (ko) | 기능적 dna 서열의 안정화된 카피 수를 갖는 미생물 및 관련 방법 | |
CN103757048A (zh) | 无抗药基因的酵母-细菌穿梭载体的构建和应用 | |
US20180094268A1 (en) | Novel promoter and use thereof | |
CN110468091B (zh) | 微生物及其用途 | |
KR20210045752A (ko) | 1,3-부탄다이올 생산용 형질전환 메탄자화균 및 이의 용도 |